| Literature DB >> 33131540 |
Hanneke M van Santen1, Wassim Chemaitilly2, Lillian R Meacham3, Emily S Tonorezos4, Sogol Mostoufi-Moab5.
Abstract
Endocrine late effects, including reproductive disorders and secondary thyroid cancer, have been reported in up to 50 %childhood cancer survivors (CCS) more than 5 years after treatment. Most endocrine disorders are amenable to treatment; awareness of symptoms is therefore of great importance. Recognition of these symptoms may be delayed however because many are nonspecific. Timely treatment of endocrine disorders improves quality of life in CCS and prevents possible consequences, such as short stature, bone and cardiovascular disorders, and depression. At-risk CCS must therefore be regularly and systematically monitored. This article provides a summary of the most commonly reported endocrine late effects in CCS.Entities:
Keywords: Bone health; Childhood cancer survivor; Growth hormone deficiency; Hypothyroidism; Late effects; Metabolic syndrome; Radiation effects; Secondary thyroid cancer
Year: 2020 PMID: 33131540 DOI: 10.1016/j.pcl.2020.08.002
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278